Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial

GLOBAL STRATEGY FOR ASTHMA MANAGEMENT AND PREVENTION

Romain Pauwels · Arerugī/Arerugi · 1996 · 10.1K citations

Pharmacy, Chronic Disease Prevention, Preventive Medicine +10

International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma

Kian Fan Chung, Sally E. Wenzel, Jan Brożek et al. · European Respiratory Journal · 2013 · 3.9K citations · Full text

Medicine, Internal Medicine, Pediatrics +13

Global asthma prevalence in adults: findings from the cross-sectional world health survey

Teresa To, Sanja Stanojevic, Ginette Moores et al. · BMC Public Health · 2012 · 1.5K citations · Full text

Public Health, Health Sciences, Global Health +10

Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial

Eugene R. Bleecker, J. Mark FitzGerald, Pascal Chanez et al. · The Lancet · 2016 · 1.4K citations

Pharmacy, Pharmacology, Pharmacotherapy +13

Benralizumab, an anti-interleukin-5 receptor α monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial

J. Mark FitzGerald, Eugene R. Bleecker, Parameswaran Nair et al. · The Lancet · 2016 · 1.4K citations

Pharmacy, Immunology, Pharmacology +17